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Abstract
Background: Alzheimer disease (AD) is a disease of lost memories. Mushroom postsynaptic spines play a key role
in memory storage, and loss of mushroom spines has been proposed to be linked to memory loss in AD.
Generation of amyloidogenic peptides and accumulation of amyloid plaques is one of the pathological hallmarks of
AD. It is important to evaluate effects of amyloid on stability of mushroom spines.
Results: In this study we used in vitro and in vivo models of amyloid synaptotoxicity to investigate effects of
amyloid peptides on hippocampal mushroom spines. We discovered that application of Aβ42 oligomers to
hippocampal cultures or injection of Aβ42 oligomers directly into hippocampal region resulted in reduction of
mushroom spines and activity of synaptic calcium-calmodulin-dependent kinase II (CaMKII). We further discovered
that expression of STIM2 protein rescued CaMKII activity and protected mushroom spines from amyloid toxicity in
vitro and in vivo.
Conclusions: Obtained results suggest that downregulation of STIM2-dependent stability of mushroom spines and
reduction in activity of synaptic CaMKII is a mechanism of hippocampal synaptic loss in AD model of amyloid
synaptotoxicity and that modulators/activators of this pathway may have a potential therapeutic value for
treatment of AD.
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Background
Alzheimer disease (AD) is the most common reason for
elderly dementia in the world, and its prevalence will
continue to increase with the aging population. The
search for effective AD therapies is an urgent need. Many
brain regions such as temporal lobe, parietal lobe, frontal
cortex and etc. are damaged in AD. Among them hippo-
campus is the best studied region. Hippocampus associ-
ated memory loss in AD results from “synaptic failure”
[1–3]. The synapse is formed by presynaptic axon ending
and by postsynaptic dendritic spine. There are three
morphological groups of dendritic spines: mushroom,
stubby and thin spines [4, 5]. It has been proposed that
mushroom spines are stable “memory spines” that make
functionally stronger synapses and therefore responsible
for memory storage [6]. Thin spines are suggested to be
“learning spines” since they response to increase and de-
crease in synaptic activity [6]. We and others previously
proposed that hippocampal mushroom spines are strongly
eliminated in AD and that loss of mushroom spines may
underlie cognitive decline during the progression of the
disease [7–11]. However, cell biological mechanisms re-
sponsible for loss of mushroom spines in AD are poorly
understood.
In the recent study we demonstrated that neuronal
store-operated calcium entry (nSOC) in postsynaptic
spines play a key role in stability of mushroom spines
[10]. We further demonstrated that synaptic nSOC is
controlled by stromal interaction molecule 2 (STIM2)
and that STIM2-nSOC pathway is downregulated in hip-
pocampal neurons from the mutant mice containing
M146V familial AD mutation in presenilin 1 (PS1-
M146V-KI) [10]. Moreover, we have demonstrated that
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expression of STIM2 protein rescues synaptic nSOC and
mushroom spine loss in PS1-M146V-KI hippocampal
neurons [10]. However, the PS1-M146V-KI mice do not
express human amyloid precursor protein (APP) and do
not generate human Aβ peptides, which believed to be
one of the key components of pathogenic process in AD
[1, 3, 12]. The goal of the present study is to evaluate
effects of human Aβ peptides on stability of mushroom
spines. By using in vitro and in vivo models of amyloid
synaptotoxicity we concluded that downregulation of
STIM2-dependent stability of mushroom spines is a
mechanism of synaptic loss in AD model of amyloid
synaptotoxicity and that modulators/activators of this
pathway may have a potential therapeutic value for treat-
ment of memory loss in AD.
Results
Amyloid oligomers destabilize mushroom spines in
primary hippocampal neuronal cultures
In our experiments we set out to establish neuronal cul-
ture model of amyloid toxicity. In these studies we focused
on soluble amyloid oligomers, which have been demon-
strated to exert synaptotoxic effects in AD [1, 12–17].
Soluble amyloid oligomers were prepared from synthetic
Aβ42 peptides by following previously described proce-
dures [18] (for details see Materials and Methods section).
The oligomeric state of resulting Aβ42 preparation was
confirmed by AFM analyses as well as by SDS gel Western
blotting experiments (Additional file 1: Figure S1). Ac-
cording to AFM data Aβ42 oligomers appear as globular
structures with 1–2 nm height and around 10 nm width
(Additional file 1: Figure S1A). Western blot experiments
showed that Aβ42 preparation is mainly in oligomeric form
and its molecular weight is around 26 kDa (Additional file
1: Figure S1B) that corresponds to pentamers or hexamers
[19]. To mimic physiological situation more closely, we
utilized low concentrations (less than 100 nM as calculated
based on initial amount of peptides utilized for preparation
of oligomers) of Aβ42 oligomers in our experiments. We
also evaluated effects of Aβ40 oligomers. Aβ40 peptides
were processed the same way as Aβ42 peptides (Additional
file 1: Figure S1A). Equivalent amounts of Aβ42 and
Aβ40 peptides were used in our experiments. Gener-
ated oligomers of Aβ42 and Aβ40 were added to DIV11
primary hippocampal neuronal cultures. In control ex-
periments neuronal cultures were treated with vehicle
(equivalent amount of growth media). At DIV14 these
cultures were fixed, permeabilized and stained for neur-
onal marker MAP2 and synaptic marker synapsin I
(Fig. 1a). To evaluate synaptogenesis state in studied
cultures, mean synapsin signal intensity was divided by
the mean of MAP2 intensity. Consistent with previous
observations [15, 16, 20], we observed significant loss




















Fig. 1 Synaptotoxic effects of amyloid oligomers in primary
neuronal cultures. a Primary hippocampal neuronal cultures exposed
to Aβ40, Aβ42 or vehicle treated (Ctrl). The cultures were fixed and
stained for synaptic marker Synapsin I (green) and neuronal marker
MAP2 (red). Scale bar corresponds to 20 μm. b Mean fluorescent
intensities of synapsin I staining were divided by mean fluorescent
intensities of MAP2 staining for hippocampal cultures treated with
Aβ40, Aβ42 or vehicle treated (Ctrl). Average results from three
independent experiments are shown. Values are shown as mean ±
SEM. *: p < 0.05 by ANOVA one-way test
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oligomers (Fig. 1a, 1b). There was also a trend towards
synaptic loss in cultures exposed to Aβ40 oligomers,
but these changes have not reached a level of signifi-
cance when compared to control cultures (Fig. 1a, 1b).
Previous studies demonstrated a shift from mushroom
to stubby synaptic spines in organotypic hippocampal
slice preparation from APPSDL transgenic mice [21]. To
analyse how synaptic spine shape is affected by applica-
tion of soluble amyloid oligomers, we adopted spine
morphology analysis approach that was used in our
previous study with PS1-M146V KI cultures [10]. In
these experiments primary hippocampal cultures were
transfected at DIV7 with plasmid expressing TD-
Tomato fluorescent protein. On DIV11 cells were
treated with Aβ40 or Aβ42 oligomers or vehicle treated.
The neurons were fixed at DIV14, imaged by confocal
microscopy and spine shapes were automatically ana-
lysed by a software (see Methods for details). Consistent
with the previous report [10], mushroom spines consti-
tuted 35 % of total spines in control (vehicle treated)
cultures at DIV 14 (Fig. 2a, 2b). Addition of Aβ40 oligo-
mers had no significant effect on mushroom spines in
neuronal cultures (Fig. 2a, 2b). In contrast, addition of
Aβ42 oligomers resulted in significant reduction in
mushroom spine proportion (Fig. 2a). On average, the
fraction of mushroom spines was reduced to 20 % in
cultures treated with Aβ42 oligomers (Fig. 2b). Following
treatment with Aβ42, the fraction of stubby spines was
increased from 35 to 50 % and the fraction of thin spines
remained constant at 26 % (Fig. 2b). The shift from
mushroom towards stubby spines induced by application
of Aβ42 oligomers is consistent with the previous results
obtained in organotypic hippocampal slices from APPSLD
transgenic model [21]. This is in contrast with our previ-
ous studies with neurons from the PS1-M146V KI mice,
where we observed the shift between mushroom and
thin spines [10].
STIM2 protein is downregulated in response to in vitro
application of amyloid oligomers
In our recent publication [10] we demonstrated that sta-
bility of mushroom spines depends on STIM2-mediated
neuronal store-operated calcium influx (nSOC) and con-
tinuous activity of Ca2+ /calmodulin-dependent protein
kinase II (CaMKII) which is enriched in synaptic spines.
To find out if this pathway affected by application of
amyloid oligomers we performed a series of Western
blotting experiments with lysates prepared from control
cultures and the cultures treated with Aβ40 and Aβ42
oligomers. In these experiments we observed approxi-
mately 20 % reduction in STIM2 expression levels in
Aβ40 and Aβ42 treated cultures (Fig. 3a, 3b). We also
observed 30 % reduction of auto-phosphorylated form of
CaMKII (pCaMKII) in Aβ42-treated cultures (Fig. 3a, 3b).
There was a trend to reduction of pCaMKII levels in
Aβ40-treated cells, but it did not reach statistical signifi-
cance (Fig. 3a, 3b). The levels of STIM1 protein and total
CaMKII levels were not affected in Aβ40 or Aβ42-treated
cultures (Fig. 3a, 3b). Notably, selective reduction in
STIM2 expression and reduced levels of pCaMKII are
similar to changes observed in our previous experiments
with PS1-M146V-KI neurons [10], suggesting that com-
mon signalling pathways are affected in synaptic spines in
both cellular models of AD pathology. However, changes
in PS1-M146V-KI neurons were more dramatic than in
Aβ42-treated neurons, with 75 % reduction in STIM2
























Fig. 2 Amyloid oligomers cause loss of hippocampal mushroom
spines in vitro. a Primary hippocampal neurons from WT mice were
transfected with TD-Tomato and visualized by confocal imaging.
Representative images are shown for cultures exposed to Aβ40,
Aβ42 or vehicle (Ctrl). Scale bar corresponds to 5 μm. On the Aβ42
panel all quantified types of spines are indicated: MS with an arrow, T
with a triangle, S with a square, dendritic elements that were not
counted as spines are labelled with a yellow star. The mean data from
four independent experiments are shown. b Average percentages of
mushroom (M), stubby (S) and thin (T) spines are shown for cultures
exposed to Aβ40, Aβ42 or vehicle (Ctrl). For spine quantification n =
8–10 (for each treatment per one experiment) neurons were analyzed.
Values are shown as mean ± SEM. **: p < 0.005 by ANOVA one-way
and post hoc tests
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STIM2 overexpression protects mushroom spines from
synaptotoxic effects of amyloid oligomers in vitro
In the previous publication [10] we demonstrated that
expression of STIM2 protein and upregulation of synaptic
nSOC pathway results in rescue of mushroom spines in
PS1-M146V-KI neurons. We supposed that the same ap-
proach could protect mushroom spines from amyloid tox-
icity. In the next series of experiments we co-transfected
hippocampal neurons at DIV7 with TD-Tomato plasmid
and the plasmid encoding mouse STIM2 (mSTIM2). On
DIV11 the cells were treated with Aβ42 oligomers or
vehicle treated. The neurons were fixed at DIV14 and
morphology of the spines was visualized by confocal im-
aging (Fig. 4a). Consistent with the previous findings
(Fig. 2), we discovered that application of Aβ42 oligomers
resulted in significant reduction in a fraction of mush-
room spines in hippocampal neurons (Fig. 4a, 4b). Expres-
sion of STIM2 had no significant effect on the fraction of
mushroom spines in control cultures, but resulted in
complete rescue of mushroom spine loss in Aβ42-treated
cultures (Fig. 4a, 4b). From these results we concluded
that expression of STIM2 is able to protect hippocampal
mushroom spines from synaptotoxic effects of Aβ42.
Injection of Aβ42 oligomers causes loss of hippocampal
mushroom spines in vivo
Do amyloid oligomers result in loss of mushroom spines
in vivo? To answer this question, we performed stereo-
taxic injections of synthetic Aβ42 oligomers to CA1
region of 2 months old line Thy1-GFP line M mice [22].
In control AFM analyses and SDS gel Western blotting
experiments we confirmed formation of oligomeric
Aβ42 species in these preparations (Additional file 1:
Figure S1A, B). The stock concentrations of Aβ42 injec-
tion solution in these experiments was equal to 1 μM
based on the initial peptide content. Control line M
mice were injected with secondary antibodies conjugated
to Alexa-555 fluorophore. Six week after injections
synaptic morphology in these mice was analysed by two-
photon imaging performed with hippocampal slices
(Fig. 5a). When obtained results were analysed, we discov-
ered that injection of Aβ42 oligomers resulted in signifi-
cant reduction in total spine density (Fig. 5b). We also
found that the fraction of mushroom spines was signifi-
cantly reduced and the fraction of stubby spines was sig-
nificantly increased in CA1 (stratum radiatum) area of












































Fig. 3 STIM2 and pCaMKII are downregulated in hippocampal cultures treated with amyloid. a The expression levels of STIM2, STIM1, pCaMKII,
and CaMKII were analyzed by Western blotting of lysates from WT hippocampal cultures exposed to Aβ40, Aβ42 or vehicle (Ctrl). Actin was used
as a loading control. b Quantification of STIM2, STIM1, pCaMKII and CaMKII expression levels in WT cultures exposed to Aβ40, Aβ42 or vehicle
(Ctrl) (normalized to actin levels). Graph represents the data from three independent experiments. Values are shown as mean ± SEM. *: p < 0.05 by
ANOVA one-way and post hoc tests, n.s. (non specific)
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(Fig. 5c). The fraction of thin spines was not affected in
these experiments (Fig. 5c). The shift from mushroom to
stubby spines observed in these experiments in response to
injection of Aβ42 oligomers is similar to results obtained in
our primary culture experiments (Fig. 2) and in published
reports with organotypic hippocampal slices [21].
Injection of Aβ42 oligomers causes downregulation of
STIM2 in vivo
In order to investigate effects of Aβ42 injections in vivo,
we performed Western blotting analyses of hippocampal
lysates prepared from wild type mice injected with Aβ42
oligomers. Mice injected with the secondary antibody
were used as a control. Consistent with hippocampal
culture data (Fig. 3) we observed 20 % reduction of
STIM2 levels in the hippocampus of the mice injected
with Aβ42 oligomers (Fig. 6a, 6b). Also consistent with
the culture data (Fig. 3), we observed 45 % reduction in
the levels of pCaMKII following injection of Aβ42
oligomers (Fig. 6a, 6b). Levels of STIM1 protein were
reduced by less than 5 % and the total levels of CaMKII
were not affected in Aβ42-injected mice (Fig. 6a, 6b).
We also evaluated levels of PSD95 protein, that is
enriched in postsynaptic density of mushroom spines.
Levels of PSD95 were also reduced by 40 % in hippo-
campus of Aβ42-injected mice (Fig. 6a, 6b). Significant
reduction of PSD95 and pCaMKII levels in these experi-
ments is consistent with the loss of mushroom spines in
hippocampal neurons of the mice injected with Aβ42
oligomers (Fig. 5) and with our previous studies with
PS1-M146V-KI mice [10].
STIM2 overexpression protects mushroom spines from
amyloid toxicity in vivo
To evaluate potential neuroprotective effects of STIM2
expression in vivo, we performed stereotaxic injections
of AAV1-mSTIM2 virus together with Aβ42 oligomers
(at 1 μM concentration) to CA1 region of 2 months old

























Fig. 4 STIM2 overexpression protects mushroom spines from amyloid toxicity in vitro. a Primary hippocampal cultures were co-transfected
with TD-Tomato and mSTIM2 plasmids or transfected with TD-Tomato. After transfection cells were treated with Aβ42 oligomers or vehicle
(Ctrl). Spine morphology was visualized by confocal imaging. Scale bar corresponds to 5 μm. Mushroom spines are indicated with an arrow.
b Percentages of mushroom spines (MS) in hippocampal cultures co-transfected with TD-Tomato and mSTIM2 or transfected with TD-Tomato.
Data collected from the three batches of cultures are shown for vehicle treated cultures (Ctrl) and cultures treated with Aβ42 oligomers. For
spine quantification n = 6–8 (for each treatment per one experiment) neurons were analyzed. Experiment was repeated three times. Values are
shown as mean ± SEM. *: p < 0.05 by t-test
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AAV1-mSTIM2 together with the secondary antibodies.
Neuronal and synaptic morphology in CA1 area (stratum
radiatum) was analysed by two-photon imaging with hip-
pocampal brain slices six weeks after injection (Fig. 7a).
Consistent with the previous findings (Fig. 5), we found
that injection of Aβ42 oligomers results in significant loss
of synaptic spines (Fig. 7b) and reduction in the fraction
of mushroom spines (Fig. 7c). Expression of STIM2 pro-
tein had no effect on total spine density or the fraction of
mushroom spines in control experiments, but resulted in
complete rescue of total spine loss and mushroom spine
loss induced by Aβ42 oligomers (Fig. 7b, 7c). To further
confirm these findings we performed Western blotting of
hippocampal lysates from these mice (Fig. 8). In these
experiments we discovered that expression of STIM2 pre-
vents reduction of PSD95 and pCaMKII levels in hippo-
campal region of Aβ42-injected mice (Fig. 8a, 8b).
Discussion
Loss of mushroom spines in cellular and animal models of AD
AD is a disease of lost memories. Studies in learning and
memory field suggested that persistent increase in syn-
aptic strength is used to achieve long-term modification
of neuronal network properties and store memories. It
has been proposed that the mushroom spines between
excitatory neurons are stable “memory spines” that make
functionally stronger synapses and therefore responsible
for memory storage [6]. By taking this one step further,
we and others previously proposed that loss of mush-
room spines may underlie cognitive decline during the
progression of the AD [7–11]. Recent experimental
evidence in several cellular and animal models of AD
provided support to this hypothesis. Fraction of mush-
room spines was significantly reduced in hippocampal
slice cultures from APPSDL transgenic mice that express
human APP695 with Swedish (KM595/596NL), Dutch
(E618Q), and London (V642I) mutations under control
of platelet-derived growth factor β promoter [21]. More
subtle model of amyloid toxicity was generated recently.
In this model human APP transgene with Dutch muta-
tion (E693Q) was expressed under control of neuronal
Thy1 promoter (DU mice) [23]. In contrast to most APP
transgenic mice, DU mice generate soluble Aβ oligomers
without formation of amyloid plaques [23]. Such pheno-
type mimics phenotype of patients with Arctic (E693G)
and E693Δ mutations that show AD phenotype in the
absence of fibrillar amyloid accumulation [24, 25]. Ana-
tomical analysis of spines in CA1 area of hippocampus
in DU mice revealed significant reduction in post-
synaptic density (PSD) of mushroom spine synapses at
12 months of age [11]. In the present study we observed
significant reduction in the fraction of mushroom spines
in neuronal cultures exposed to Aβ42 oligomers (Fig. 2)
and in CA1 area (stratum radiatum) of hippocampus of
the mice injected with Aβ42 oligomers (Fig. 5). Although
Price at al have not reported reduction in the fraction of
mushroom spines in their analysis of DU mice [11],
there was a trend to reduced mushroom spine density in
their data (Fig. 3 in Price et al., 2014). Most likely
concentration of Aβ42 oligomers in our study was
higher than in the DU mice, leading to more dramatic
destabilization of mushroom spines in our experiments.









































Fig. 5 Influence of Aβ42 on mushroom spines in vivo. a The spine
shape of CA1 hippocampal neurons from the 3.5 months old line M
mice injected with Aβ42 and control mice was visualized by two-
photon imaging. Scale bar corresponds to 5 μm. On the Ctrl panel
all quantified types of spines are indicated: M (mushroom) with an
arrow, T (thin) with a triangle and S (stubby) with a square. b, c Total
spine density and percentages of mushroom, thin and stubby spines
in neurons from CA1 hippocampal area. Graph represents the data
of three independent experiments with control mice and the mice
injected with Aβ42. For spine quantification n = 21–30 neurons were
analyzed. Values are shown as mean ± SEM. ***: p < 0.0005 by t-test
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amyloid toxicity models. In the recent study we observed
significant loss of mushroom spines in hippocampal
neurons from PS1-M146V-KI mouse model [10]. Thus,
loss of mushroom spines appear to be a common feature
of AD models, in agreement with our hypothesis [7, 9].
Important to note that there is a correlation between
dendritic spines alterations in CA1 area of hippocam-
pus and memory impairments in different mice models
of AD. Loss of mushroom spines in CA1 hippocampal
neurons in PS1-M146V-KI [10] may underlie disrupted
late-phase LTP and age-related alterations in hippocampal
spatial memory observed in these mice [26]. Twelve
month old DU mice have decreased PSD length and
trend to reduced mushroom spine density in CA1 area
as well as diminished performance in the water maze
indicating that these mice exhibit perturbed hippocampus-
associated spatial learning and memory [11]. It has been
demonstrated that the Aβ-mediated impairment of mem-
ory in rats is associated with lower density of synapses and
altered synaptic structure in both the dentate gyrus and
CA1 fields [27].
Synaptic CaMKII and stability of mushroom spines
What are the signalling pathways that maybe responsible
for mushroom spine loss in AD? We previously pro-
posed that stability of the mushroom spines is deter-
mined by a balance between activity of synaptic CaMKII
and calcineurin [28]. Tackenberg at al (2009) demon-
strated that inhibition of NMDAR rescues mushroom










































Fig. 6 STIM2, PSD95 and pCaMKII are downregulated in mice injected with Aβ42. a The expression levels of STIM2, STIM1, PSD95, pCaMKII,
CaMKII were analyzed by Western blotting of hippocampal lysates taken from wild type mice injected with Aβ42 and from the control mice. Each
band on WB panel represents one mice. Actin was used as a loading control. b Expression of STIM2, STIM1, PSD95, pCaMKII, and CaMKII proteins
was normalized to actin. Values are shown as mean ± SEM for control mice and the mice injected with Aβ42. *: p < 0.05, **: p < 0.005 by t-test
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further argued that activation of postsynaptic calcineurin
downstream of NMDAR leads to mushroom spine loss
in APPSDL slices in their experiments [21]. Price et al.
(2014) did not dissect signalling pathways responsible
for mushroom spine PSD shrinkage in DU mouse model
[11]. Results observed in the current study suggest that
activity of synaptic CaMKII has been reduced following
application of Aβ42 oligomers. Indeed, we observed sig-
nificant reduction in pCaMKII signals in hippocampal
neurons following exposure to Aβ42 in vitro (Fig. 3) and
in vivo (Fig. 6). These effects were specific for active syn-
aptic CaMKII, as total levels of CaMKII were not af-
fected by Aβ42 oligomers in these experiments (Figs. 2
and 6). These results are consistent with the previously
reported loss of synaptic localization of CaMKII in cor-
tical neurons from APP transgenic mice (APP Swedish
mutation, KM670/671NL) or in cortical cultures ex-
posed to Aβ peptides [29]. Similar reduction in pCaMKII
levels was observed in our recent study in hippocampal
neurons from PS1-M146V-KI mouse model [10]. More-
over, reduction in hippocampal pCaMKII levels was ob-
served in our experiments as a part of normal aging
process [10]. Thus, reduction of synaptic CaMKII activ-
ity appears to be a common feature of AD mouse
models and probably relevant for aging-related memory
impairment as well. Importantly, dysregulated phosphor-
ylation of synaptic CaMKII was reported at MCI stage of
human AD [30], suggesting that reduced activity of syn-
aptic CaMKII may indeed contribute to human disease.
Synaptic STIM2-nSOC pathway as novel therapeutic target
for AD
It follows from the above discussion that activators of
synaptic CaMKII should expert neuroprotective effects.
Indeed, overexpression of CaMKII protected synaptic
function in Aβ42-treated cortical neurons [29]. However,
direct expression of CaMKII is not likely to become a vi-
able therapeutic strategy for AD. In the previous study
we discovered that activity of synaptic CaMKII is regu-
lated via STIM2-nSOC Ca2+ influx pathway [10]. We
further demonstrated that STIM2 levels are reduced in
PS1-M146V-KI hippocampal neurons and that overex-
pression of STIM2 rescues pCaMKII activity and mush-





































Fig. 7 STIM2 overexpression protects mushroom spines from amyloid toxicity in vivo. a The spine shape of CA1 hippocampal neurons from
3.5 months old line M mice injected with AAV1-mSTIM2 (S2), Aβ42, control mice (Ctrl), and Aβ42 together with AAV1-mSTIM2 (S2) was visualized
by two-photon imaging. Scale bar corresponds to 5 μm. Mushroom spines are indicated with an arrow. b, c Total spine density and percentages
of mushroom spines (MS) in neurons from CA1 hippocampal area of mice injected with AAV1-mSTIM2 (S2), control mice, mice injected with
Aβ42 and mice injected with Aβ42 together with AAV1-mSTIM2 (S2). Graph represents the data of three independent experiments. For spine
quantification n = 21–30 neurons were analyzed. Values are shown as mean ± SEM. ***: p < 0.0005 by t-test
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STIM2-nSOC signalling pathway was also observed in
recently developed APP-KI mouse model [31]. In the
present study we discovered that STIM2 levels are re-
duced in neuronal cultures exposed to Aβ42 and Aβ40
oligomers (Fig. 3) and in hippocampus of the mice
injected with Aβ42 oligomers (Fig. 6). Similar to study
with PS1-M146V-KI mice, these effects were specific for
STIM2 with minimal effect on STIM1 (Figs. 3 and 6).
However, effects on STIM2 expression were less dramatic
in conditions of amyloid toxicity (present study) than in
experiments with PS1-M146V-KI neurons [10]. It appears
that the downregulation of STIM2-nSOC pathway is a
primary mechanism responsible for mushroom spine loss
in conditions of ER Ca2+ dysregulation resulting from
PS1-M146V-KI mutation [10, 32]. In contrast, Aβ42 oligo-
mers more likely to act on other Ca2+-related postsynaptic
targets such as NMDAR [33] and mGluR5 [20, 34], with
downregulation of STIM2-nSOC pathway occurring as
a secondary event. Interestingly that Aβ40 significantly
reduced expression of STIM2 (Fig. 3) but didn’t signifi-
cantly influence expression of pCaMKII (Fig. 3) and
stability of mushroom spines (Fig. 2). We speculate that
Aβ40 at nanomolar concentration doesn’t affect post-
synaptic Ca2+-channels (such as mentioned above).
Therefore, in our experimental conditions Aβ40 is not
as toxic as Aβ42 and doesn’t cause reduction in pCaM-
KII and mushroom spines numbers.
Critically, we demonstrated that overexpression of
STIM2 rescued mushroom spine loss in cultures exposed
to Aβ42 oligomers (Fig. 4), rescued mushroom spine loss
(Fig. 7) and pCaMKII levels (Fig. 8) in the hippocampus of
the mice injected with Aβ42 oligomers. It appears that en-
hanced activity of STIM2-nSOC pathway was sufficient to
rescue activity of synaptic CaMKII and protects mush-
room spines in conditions of amyloid toxicity as well as in
conditions of ER Ca2+ dysregulation due to PS1-M146V
mutation. From these results we concluded that activators
of STIM2-nSOC synaptic Ca2+ influx pathway may have a
therapeutic value for treatment of AD.
Conclusions
Obtained results lead us to conclude that loss of mushroom
spines is a common feature of AD models and it is
observed in presenilin mutant neurons [10] and in condi-
tions of amyloid toxicity [8, 11, 31], (present study). We fur-
ther conclude that reduction in synaptic activity of CaMKII
is a likely cause of mushroom spine destabilization in AD
models [10, 29, 31], (present study) and in human AD [30].
Expression of STIM2 protein rescued CaMKII activity and
mushroom spine defects in presenilin model of AD [10]
and in conditions of amyloid toxicity (present study). Thus,
positive modulators of STIM2-nSOC may constitute poten-




Albino outbred mice (Rappolovo farm, Leningradsky
District, Russia) were used as source of brain tissue for
experiments with hippocampal cultures. Pilot culture ex-
periments were performed with neurons from the FVB
strain pups. Obtained results were similar to results ob-
tained with albino outbred mice (data not shown).
Therefore genetic background should not influence the
reproducibility of neuronal culture experiments in this
study. Line M mice Tg(Thy1-EGFP)MJrs/J [22] was used
in imaging experiments. Line M mice were obtained from
the Jackson Laboratory (Stock Number: 007788) and the
breeding colony was established in the animal facility
located in the Laboratory of Molecular Neurodegeneration
in St Petersburg State Polytechnical University. Western











































Fig. 8 STIM2 overexpression rescues levels of PSD95 and pCAMKII
proteins in conditions of amyloid toxicity in vivo. a The expression
levels of STIM1, PSD95, pCaMKII, and CaMKII were analyzed by Western
blotting of hippocampal lysates taken from 3.5 months old mice
injected with AAV1-mSTIM2 (S2), Aβ42, control mice (Ctrl), and Aβ42
together with AAV1-mSTIM2 (S2). Each band on WB panel represents
one mice. Tubulin was used as a loading control. b Expression of
STIM1, PSD95, pCaMKII, CaMKII proteins was normalized to tubulin.
Mean values from 3 independent experiments are shown as mean ±
SEM for the mice injected with AAV1-mSTIM2 (S2), Aβ42, control mice
(Ctrl), and Aβ42 together with AAV1-mSTIM2 (S2). *: p < 0.05, **:
p < 0.005 by t-test
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WT mice (C57BL/6 J background) obtained from the
Jackson Laboratory (Stock Number: 000664). All proce-
dures involving mice were approved by the Institutional
Animal Care and Use Committee of the Research Insti-
tute of Influenza Ministry of healthcare of the Russian
Federation, in accord with the Ministry of agriculture
of the Russian Federation guidelines.
Plasmids and viruses
pCSCMA-TD-tomato plasmid was purchased from
Addgene. Generation of mSTIM2 expression plasmid
and AAV1-mSTIM2 adeno-associated virus was previ-
ously described [10]. The high titer stock of AAV1-
mSTIM2 virus (titer >1013 vp/ml) was obtained from the
University of Iowa Gene Transfer Vector Core.
Aβ40 and Aβ42 preparation
Aβ42 (#20276) and Aβ40 (#24236) peptides were pur-
chased from AnaSpec (Fremont, USA). A lyophilized ali-
quot (1 mg) of Aβ42 and Aβ40 peptides was dissolved in
80 μl of 1 % NH4OH and then in 920 μl of sterile
phosphate-buffered saline (PBS) to get stock solution with
concentration 1 mg/ml (stored as 100 μl aliquots at – 20 °
C). Working Aβ solutions were made immediately before
treatment of the cells by diluting stock concentration to
0.1 μM final Aβ peptide concentrations in Neurobasal-A
medium (Gibco, Life technologies, USA). Working solu-
tions were incubated at + 4 °C 24 h to obtain the oligo-
meric conditions as described by Zheng et al. [18]. At the
day of the usage working solutions were centrifuged at
14000 g, + 4 °C, 10 min to purify oligomeric Aβ fraction
from fibrils. Composition of supernatant fraction was
confirmed by atomic force microscopy (Additional file 1:
Figure S1A) and by denaturating (0.1%SDS) 15 % gel elec-
trophoresis followed by Western blot with anti-Aβ 6E10
monoclonal antibodies (Covance, SIG-39320) (Additional
file 1: Figure S1B). Western blot was repeated three times.
Amounts of Abeta loaded per gel lane are 1.2 nmol for
Aβ42 and Aβ40 and 12 nmol for Aβ42-555. The super-
natant fractions containing Aβ oligomers were used to
treat hippocampal cultures. In experiments with stereo-
taxic injections Aβ42 peptides conjugated with Alexa-555
fluorophore were used (#60480-01, AnaSpec). Working so-
lutions of Aβ42 peptides peptides for in vivo experiments
were 1 μM. Other steps in preparation of working solution
were the same as described above for in vitro experiments.
Primary hippocampal cultures
The hippocampal cultures from albino outbred mice were
established from postnatal day 0–2 pups and maintained
in culture as we described previously [10, 32]. Both hippo-
campi from pups were dissected in sterile ice cold
1XHBSS buffer (pH 7.2). Hippocampi were dissociated in
papain solution (Worthington 3176) at 37 °C, 30 min. To
remove big undissociated cell aggregates solution with
hippocampal neurons were twice triturated in 1 μg/ml
DNAseI (Sigma, DN-25). To remove DNAseI neurons
were centrifuged at 1500 rpm, 4 min. Supernatants dis-
carded and fresh warm (37 °C) growth medium (Neuroba-
sal-A (Gibco, 10888), 1xB27 (Gibco, 17504), 1 % heat
inactivated FBS (Gibco, 16000), 0.5 mM L-Glutamine
(Gibco, 25030)) was added. Neurons were plated in 24
well plate containing 12 mm round Menzel cover slip (d0-
1) precoated with 1 % poly-D-lysine (Sigma, p-7886). Neu-
rons were seeded at ~5×104 cells per well (24 well format).
Growth medium was changed on the next day after plat-
ing then weekly. In control experiments neuronal cultures
were treated with equivalent amount (same volume as
used to prepare Aβ solutions) of Neurobasal A incubated
at + 4 °C 24 h (vehicle).
Immunohistochemistry
Hippocampal primary neurons from albino outbred
mice were fixed with fixation solution (4 % formalde-
hyde in PBS, pH 7.4) for 30 min at room temperature,
washed three times with PBS with 0.05 % Tween-20
then incubated at room temperature for 1 h in 5 % BSA
in PBS buffer. Primary antibodies anti-map2 mAb
(1:1000, Chemicon, mAB378) and anti-synapsin I
(1:1000, Chemicon, Temecula, CA) were diluted in
2.5 % BSA in PBS with 0.025 % Tween-20 and incu-
bated at room temperature for 3 h. After three times
wash, the hippocampal cultures were incubated in
2.5 % BSA in PBS solution with the secondary antibody
(1:1000, Alexa Fluor 488 or 594, Invitrogen) for 1.5 h at
room temperature and visualized by a confocal micro-
scope (Thorlabs, Russia). In order to compare data
from different culture experiments mean fluorescent
intensity of Channel A (synapsin) was divided by the
mean fluorescent intensity of Channel B (MAP2).
Calcium-phosphate transfection of primary hippocampal
cultures
Calcium-phosphate transfection of primary hippocam-
pal cultures was done as previously described [10, 32].
Changes to published protocol were in following steps:
transfection medium was prepared 4 days before trans-
fection (to equilibrate osmolality of transfection
medium with growth medium); at the day of transfec-
tion MgCl2 was added to the transfection medium to
the final concentration 10 mM and sterile filtered mix-
tures of plasmids with CaCl2 were incubated during 5-
7 min at room temperature. Calcium transfection kit
was purchased from Sigma (CAPHOS).
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Dendritic spine analysis in primary hippocampal neural
cultures
Dendritic spines can be classified into three types: mush-
room, thin and stubby. However, sometimes spines of
unknown shape such as spines with two heads, spines
with common neck (Fig. 2a, Aβ42 sample) or spines
with transitional states can be identified. For better un-
derstanding of spine analysis we have labelled all spines
that were counted and dendritic segments that were not
counted as spines in Fig. 2a. Different types of spines are
indicated as following: MS (mushroom spine) with an
arrow, T (thin) with an triangle and S (stubby) with
square. Those spines that have not been characterized as
mushroom, thin or stubby have been labelled with a yel-
low star (Fig. 2). For assessment of synapse morphology,
hippocampal cultures were transfected with TD-tomato
plasmid at DIV7 using the calcium phosphate method
and fixed (4 % formaldehyde in PBS, pH 7.4) at DIV14.
A Z-stack of optical section was captured using 100X
objective (1.4 NA Olympus, UPlanSApo) with a confocal
microscope (Thorlabs, USA). Each image maximal reso-
lution was 1024 × 1024 pixels with 0.1 μm/pixel and av-
eraged six times. Total Z volume was 6 – 8 μm imaged
with Z interval 0.2 μm. At least 18 transfected neurons
for each treatment from three independent experiments
were used for quantitative analysis. Quantitative analysis
for dendritic spines was performed by using freely avail-
able NeuronStudio software package [35] as we previ-
ously described [10]. To classify the shape of neuronal
spines in culture, we adapted an algorithm from published
method [35]. In classification of spine shapes we used the
following cutoff values: aspect ratio for thin spines
(AR_thin(crit)) = 2.5, head to neck ratio (HNR(crit)) = 1.4,
and head diameter (HD(crit)) = 0.45 μm, the Z interval
was 0.2 μm. These values were defined and calculated
exactly as described by previous report [35].
Stereotaxic injection
The stereotaxic injections of AAV1-mSTIM2 virus or
Aβ42 oligomers in CA1 area (stratum pyramidale) of
hippocampus were performed as described previously
[10]. Mice were injected with 5 ul of Aβ42-Alexa555
oligomer, prepared as described above. Additionally, 1 μl
of AAV1-mSTIM2 virus was injected each side. Control
mice were injected with 5 μl of secondary anti-mouse
antibody Alexa-555 (Invitrogen, A11005) diluted in
Neurobasal-A to the concentration 1 μM and incubated
at + 4 °C 24 h. For bilateral hippocampus injection, the
Hamilton injection syringes were positioned at a 10 ° angle
on both sides and the optimal injection coordinates (from
bregma) were anterior/posterior (AP) -2.0 mm, lateral
+2.6 mm, dorsal/ventral-1.9 mm. 1 μl of virus was injected
each side. For STIM2 overexpression, 12 Thy1-GFP and
12 WT mice were injected at 8 weeks of age, 3 mice for
each experimental group.
Western blot analyses
Hippocampal regions from WT mice at 3.5 month were
dissected, homogenized, and solubilized at 4 °C for 1 h in
lysis buffer (1 % CHAPS, 137 mM NaCl, 2.7 mM KCl,
4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2, 5 mM
EDTA, 5 mM EGTA, 1 mM PMSF, 50 mM NaF, 1 mM
Na3VO4 and protease inhibitors). Primary hippocampal
neurons were collected, homogenized and solubilized in
the same buffer on DIV14. The total protein lysates were
separated by SDS-PAGE and analyzed by Western blot-
ting with anti-STIM1 pAb (1:1000, Cell Signaling, 4916 s),
anti-STIM2 pAb (1:1000, AnaSpec, 54681), anti-Phospho-
CaMKII (1:2000, Abcam, ab171095), anti-CaMKII
(1:1000, Chemicon, MAB8699), anti-PSD95 (1:1000, Cell
Signaling, 3450 s), anti-actin clone C4 (1:1000, Millipore,
MAB1501) and anti-tubulin (1:1000, DSHB, E7-c). HRP-
conjugated anti-rabbit (1:2000, DAKO, P0448) and anti-
mouse (1:2000, DAKO, P0447) secondary antibodies.
Analysis of the data was performed using Quantity One
from BioRad software. The mean density of each band
was normalized to actin or tubulin signal in the same sam-
ple and averaged. All Western blots replicated 3–7 times.
Dendritic spine analysis in mice hippocampus
Six weeks after virus injection Thy1-GFP mice were
anesthetized with 200 μl of 250 mg/ml Urethane (Sigma,
U2500-250G), then intracardially perfused with ice cold
1.5 % paraformaldehyde (PFA) solution in phosphate
buffer (pH 7.4) 30 ml in 3 min. The brains were ex-
tracted and post-fixed in 1.5 % PFA solutions for 16 h
before cutting. Thick (300 μm) hippocampal sections
from the fixed brains were obtained using vibratome
(WPI, NVSLM1, USA) and floated in 0.5 % PFA solution
at 4 °C. Brain slices analyzed by two-photon imaging
(Thorlabs, USA) with 20X lens (1 NA Olympus, XLUM-
PlanFl N). The Z interval was 0.5 μm. Aβ42 after injec-
tion are spread along CA1 area (Additional file 2: Figure
S2). In mice injected with Aβ42 and control mice
injected with Alexa555-labeled antibody, with or without
AAV-mSTIM2, the secondary apical dendrites of hippo-
campal CA1 pyramidal neurons were selected for taking
images. Each image was acquired at 1024 × 1024 pixels
with the pixel size 0.065 μm and averaged twelve times.
Seven to nine neurons were analyzed per animal, ap-
proximately 20–30 neurons from 3 mice for each group.
To classify the shape of neuronal spines in slices we used
NeuronStudio software package and an algorithm from
[35] with the following cutoff values: AR_thin(crit) = 2.5,
HNR(crit) = 1.3, HD(crit) = 0.2 μm. Acquisition of the
images as well as morphometric quantification was per-
formed by ‘blinded’ operators.
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Statistical analyses
The results are presented as mean ± SEM. Statistical
comparisons of results obtained in experiments were
performed by Student’s t test for two-group compari-
sons. ANOVA one way and post hot test were used for
comparison of data from more than two groups. The
statistical method and p values are indicated in figure
legends as appropriate.
Additional files
Additional file 1: Figure S1. Characterization of oligomeric state of
Aβ42, Aβ40 and Aβ42-Alexa555. (A) Atomic force microscopy (performed
as described in Additonal file 3) images of Aβ42, Aβ40 and Aβ42-
Alexa555 samples after 24 h incubation at 4 °C visualized on graphite.
Sizes of field of view for left images are 4×4μm and for right images
1×1μm. Topographic profile for each Aβ sample is presented (measured
globule is marked with blue line). All Aβ samples appear primarily as
globular structures with following sizes: Aβ42 height 1.56 ± 0.3 nm, diam-
eter at fwhm before deconvolution 75 ± 0.6 nm, diameter at fwhm after
deconvolution 9.6 ± 0.1 nm; Aβ40 height 0.9 ± 0.1 nm, diameter at fwhm
before deconvolution 43 ± 0.3 nm, diameter at fwhm after deconvolution
7.3 ± 0.1 nm; Aβ42-Alexa555 height 1.46 ± 0.2 nm, diameter at fwhm be-
fore deconvolution 68 ± 0.6 nm, diameter at fwhm after deconvolution
8.9 ± 0.1 nm. (B) Supernatant fractions of Aβ42, Aβ40 and Aβ42-Alexa555
preparations were separated on 15 % Acrylamide/Bis SDS gel and ana-
lyzed by Western blotting with anti-Aβ 6E10 monolconal antibodies. (PDF
375 kb)
Additional file 2: Figure S2. Visualization of hippocampal neurons
injected with Alexa-555 labelled Aβ42. Low-magnification image of CA1
hippocampal area from 3.5 months old Thy1-GFP line M mouse is pre-
sented. Image is taken six weeks after injection. CA1 neurons expressing
GFP protein are shown in green, signals from Alexa-555 labeled Aβ42 are
shown in red. The specific dendritic segment where the data on spine
density and shape were obtained is marked with white circle. Scale bar
corresponds to 20 μm. (PDF 51 kb)
Additional file 3: Supplementary experimental procedure. Atomic
force microscopy. Imaging was performed on commercial SPM Solver P47-
Pro atomic force microscope with NSG 11 probe (Nt-MDT Co., Zelenograd,
Moscow, Russia). Images were taken in air using tapping mode on highly
ordered pyrolytic graphite (Nt-MDT Co., Zelenograd, Moscow, Russia). The
surface of graphite was carefully rinsed with deionized water and gently dried
under a N2 stream. NovaRC1 operating software version 850 was used to
acquire the data images, Gwyddion and SPIP software were used to render
the data and perform the analyses. The z-height of 9-10 globules from two
different areas on the graphite was measured. Particle analysis was performed
by choosing a threshold height equivalent to 1/2 the average z-height of the
globules. This measures globule diameter at fwhm (full width at half-
maximum). To get approximate width of globules geometrical deconvolution






h is the real width of the structure, w is the width or diameter observed in the
AFM image, and Rt is the tip apex radius (in our case it is around 10 nm).
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